Lung cancer and Melanoma Flashcards

1
Q

State the 4 most common symptoms of lung cancer

A
  • Persistent unexplained cough lasting more than 3 weeks
  • Haemoptysis
  • SOB
  • Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

State some investigations for suspected lung cancer

A

Initial:
- Bloods
- CXR

Further:
- Biopsy for histology (CT-guided, bronchoscopy or thoracoscopy if pleural effusion)
- Staging CT
- Evaluate fitness and lung function tests (helps predict whether surgery will leave patient breathless after)

Followed by MDT discussion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State some bloods to do for suspected lung cancer

A

Calcium is VERY important - most common sign found in lung cancer
- FBC
- U&Es
- Calcium (most common sign)
- LFTs (check for liver mets)
- INR (check for liver mets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

State some histology options for biopsy in lung cancer

A

Choose based on whether the tumour is central, peripheral or peri-bronchial/para-tracheal

  • Sputum cytology
  • Bronchoscopy
  • EBUS-TBNA (specific type of bronchoscopy)
  • CT guided lung biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State some investigations for malignant pleural effusion

A
  • Bloods (same as standard suspected lung cancer)
  • US guided aspirate and cytology/microbiology

If cytology from US guided aspirate if negative, need to do a medical thoracoscopy

Pleural effusion cancer cannot be cured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State an incidental nodule and why is it significant in lung cancer

A

“blob” in the lung >5mm

Significant as it may represent early cancer - if > 20mm then 50% chance of developing cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State how MSCC (metastatic spinal cord compression) can present and how to manage

A

Presentation:
- Upper motor neurone signs
- Back pain (progressive, unremitting, worse on straining)
- Localised tenderness over affected area
- Urinary retention / constipation
- Sensory loss in saddle area

Management:
- Urgent MRI with discussion with spina surgeon and oncologist
- Urinary catherisation
- High dose steroids (IV or PO) e.g. oral Dexamethasone 16mg
- Radiotherapy / surgical decompression (depending on prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State how manage hypercalcaemia in lung cancer

A
  • IV fluids for around 48 hours (dilute calcium)
  • Pamidronate infusion over 30-60 mins (drives Ca back into cells) (Zoledronate in breast or prostate cancer)

This will control calicum for around 6 weeks - in time to manage underlying condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State how SVC obstruction can present, suggested imaging and how to manage (acute and long term)

A

Presentation:
- Localised oedema of the face and upper extremities
dyspnoea
- Dyspnoea
- Cough
- Facial plethora
- Distended neck/chest veins
- Hoarseness of voice

Suggested imaging:
- Chest x-ray
- CT scan (staging CT helpful)

Acute management:
- Sit patient upright
- Oxygen
- Analgesia if needed
- Dexamethasone to reduce swelling and oedema

Definitive management:
- Urgent CT staging and biopsy to determine cause
- Stent the SVC
- Radiotherapy (if caused by non-small cell)
- Urgent chemo (if caused by small cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State some causes of hyponatraemia in lung cancer and how to manage acutely

A

Paraneoplastic syndromes:
- Cushing’s syndrome
- Hypertrophic pulmonary osteoarthropathy
- Lambert-Eaton syndrome
- SIADH
- Trousseau’s syndrome

Last less than 3 months :(

Management:
- Admit to hospital
- Fluid restriction
- Demeclocycline
- Tolvaptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

State some oncological emergencies in lung cancer

A
  • MSCC
  • Hypercalcaemia
  • SVC obstruction / compression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State how to manage headache and brain mets

A

1) CT scan
2 ) Followed by MRI brain

  • Start Dexamethosone 4mg bd
  • Can give stereotactic radiosurgery (SRS) if < 5 brain mets
  • If seizures, give Keppra

Shouldn’t be driving!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State the pathway for someone presenting with suspected lung cancer from an abnormal CXR

A
  • Triage by LC Physician - decide stage/investigations
  • Urgent CT
  • OPD appointment, see patient in clinic (LC Physician & Specialist Nurse) – Break Bad News, explain diagnostic plan
  • Discuss at LC MDT – decision on treatment modality and update patient
  • Patient seen by appropriate MDT specialist to commence treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

State the time limits for a patient with suspected cancer

A
  • No more than 62 days (2 months) from the date the hospital receives an urgent suspected cancer referral and the start of treatment
  • No more than 31 days from the meeting at which you and your doctor agree the treatment plan and the start of treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State some types of lung cancer surgery

A
  • Wedge resection (early disease and small tumour)
  • Lobectomy
  • Pneumonectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State the major subtypes of lung cancer

A

1) Small cell (rapidly progressive) = chemo-sensitive

2) Non-small cell:
- Squamous
- Lung adenocarcinoma (mutation driven, not associated with smoking)
- Large cell carcinoma (doesn’t respond well to chemotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

State some characteristics of the major subtypes of cancer

1) Small cell

2) Non small cell
a) Squamous cell
b) Adenocarcinoma
c) Large cell

A

1) Small cell (20%)
- Arise from APUD cells
- Tend to cause paraneoplastic syndromes
- Tend to be more central
- Rapidly progressive
- But respond well to chemotherapy (not to surgery)

2) Non-small cell:
a) Squamous cell (35%)
- Arise from epithelial cells lining airways
- So tend to be more central
- Metastasise later than other types
- More likely to cause lung collapse or blockages
b) Adenocarcinoma (32%)
- Arise from peripheral, mucous secreting cells
- So tend to be more peripheral
- Less associated with smoking
c) Large cell (10%)
- Undifferentiated cancers and tend to lack structure of other 2 types
- Doesn’t respond well to chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

State some changes that could be seen on a chest x-ray in a patient with suspected lung cancer

A
  • Visible mass
  • Mediastinal widening
  • Hilar lymphadenopathy
  • Lobar collapse
  • Pleural effusion

However none of the findings of diagnostic, requires histology and staging CT scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

State the 4 types of radiotherapy methods for lung cancer and when they are used

A

1) Radical - high dose with curative intent

2) SABR - focussed for smaller cancer with curative intent

3) Palliative - small dose for symptom control only

4) Intraluminal brachytherapy - if cancer is growing into central airways

20
Q

State some palliative interventions for lung cancer

A
  • YAG laser
  • Cryotherapy
  • Diathermy
  • Brachytherapy
  • Bronchial stents
22
Q

State the NICE guidelines for lung cancer referral

A

> 40 with 2 or more of the following:
- Cough
- Fatigue
- SOB
- Chest pain
- Weight loss
- Appetite loss

If ever smoked - only need 1 of the above

Refer for a 2WW chest x-ray

23
Q

State what pathway would the following scenarios cause
- >40 with haemoptysis
- CXR findings suggest lung cancer

A

2WW appointment to see chest physician

24
Q

State the difference between EBUS, bronchoscopy alone and percutaneous CT-guided biopsy

A

EBUS - samples the lymph node (or multiple depending on results of PET-CT scan)
Bronchoscopy alone - samples cancer itself (cancer must be invading into bronchiole)

Use EBUS if there is lymph node involvement, if not need to do bronchoscopy alone

CT guided biopsy - samples cancer itself, especially for peripheral tumours (more invasive but good if further out)

25
State the risks and benefits of EBUS
26
State the risks and benefits of bronchoscopy alone (biopsy)
27
State the risks and benefits of percutaneous CT-guided biopsy
28
State 3 main subtypes of melanoma
1) Superficial spreading (70-80% of melanomas) 2) Nodular 3) Lentigo
29
Outline the 3 main subtypes of melanoma 1) Superficial spreading 2) Nodular 3) Lentigo
1) Superficial spreading (70-80% of melanomas) - Relatively slow growing in early stages (should be readily detectable) - Irregular in shape - Irregular in colour - Progressively changing Also subtype of 'spitzoid' melanoma (which is 'new', 'juicy' and more regular in shape) 2) Nodular - Faster growing - Raised nodule - Slightly or deeply pigmented - Often friable / vascular 3) Lentigo - Precursor of melanoma, in situ - Very slow growth - Associated with chronic sun exposure
30
Melanoma - state the following: - Pathophysiology - Location (where are they found on the body) - Risk factors - Presentation - Investigation - Management
Pathophysiology: - Aggressive form of skin cancer, arising from abnormal melanocyte growth - Presents as changes to / new pigmented lesions on the skin Location (where are they found on the body) Presentation - ABCDE: Asymmetry Border is irregular Colour variation Diameter >6mm Evolution / elevation Investigations: - Excision biopsy - Sentinel lymph node biopsy (if the Breslow thickness is >1mm) - Further imaging e.g. PET CT if suspicion of mets Management: - Surgical excision (margin determined by Breslow thickness) - Some additional treatments if needed e.g. radiotherapy, immunotherapy or BRAF inhibitors (do immunotherapy first then BRAF if positive)
31
State some risk factors for melanomas
- Family history or prior personal history of melanoma - High levels of sun or UV exposure - Fitzpatrick type I or II - Immunosuppression - Older age / male - Smoking
32
Actinic (solar) keratoses - state the following: - Pathophysiology - Location (where are they found on the body) - Risk factors - Presentation - Management
Pathophysiology: - Dysplastic (precancerous condition) - Lesions which are yellowish or erythematous, ill-defined, irregularly shaped, small, scaly macules or plaques - Can potentially progress into squamous cell carcinoma (SCC) Location: - Occur at sun exposed sites e.g. head, ears Risk factors: - Fair skinned - Outdoor occupation - Older age Presentation: - Scaly rough patch, on erythematous background - Feels like sandpaper Management: - Sun protection e.g. hats, sunscreen - Cryotherapy (liquid nitrogen) - 5-FU cream or Imiquimod - Surgical excision / curettage and cauterisation - Photodynamic therapy
33
Bowen's disease - state the following: - Pathophysiology - Location (where are they found on the body) - Risk factors - Presentation - Management
Pathophysiology: - Also known as SCC in situ - Dysplastic (precancerous condition) changes in the epidermis - Non-itchy lesions, fixed, erythematous patches of skin - Can potentially progress into squamous cell carcinoma (SCC) Location: - Commonly occur on lower legs of women - Can occur on hands and nails Risk factors: - HPV - Exposure to oils - Fair skinned - Outdoor occupation - Older age Presentation: - Often multiple lesions - Non-itchy, fixed, erythematous patches of skin - Slightly scaly - Don't respond to moisturisers or topical steroids Management: - Sun protection e.g. hats, sunscreen - 5-FU cream or Imiquimod - Surgical excision / curettage and cauterisation - Photodynamic therapy Cryotherapy - less good as wounds take a long time to heal
34
Basal cell carcinoma - state the following: - Pathophysiology - Location (where are they found on the body) - Risk factors - Presentation - Management
Pathophysiology: - Most common non-melanoma skin cancer - Malignant tumour of the keratinocytes within the epidermis - Can be locally invasive, but very rarely metastasises (often in larger tumours) - Common have multiple tumours - important to check whole of skin - Associated with higher risk of other skin cancers (e.g. melanoma and SCC) Location: - Commonly sun-exposed areas of the face (commonly temples) Risk factors: - Fair skinned - Childhood sunburn - Family history - Immunosuppressed Presentation: - Shiny, pearly nodule (sometimes a umbilical, necrotic or ulcerated center) - Telangiectasia - Appear translucent (don't produce a lot of keratin) Commonly can have multiple nodules Management: - Excise tumour (Moh's micrographic surgery) if high risk e.g. near eyes, ill defined etc. - Radiotherapy in poor surgical candidates - Other options for smaller lesions e.g. curettage and cautery Future = sun protection e.g. hats, sunscreen
35
Squamous cell carcinoma - state the following: - Pathophysiology - Location (where are they found on the body) - Risk factors - Presentation - Management
Pathophysiology: - 2nd most common non-melanoma skin cancer - Locally invasive malignant tumour of epidermal keratinocytes - Metastasis is uncommon (higher risk if large and poorly differentiated) Location: - Commonly sun-exposed areas of the face Risk factors: - Fair skinned - Outdoor occupation - Older age - Sun exposure - Chronic inflammation / actinic (solar) keratosis - Immunosuppression Presentation: - Warty tumour (keratin) upon a fleshy base - Can appear as ulcerated nodules if more advanced (poorer prognosis) Management: - Excise tumour if high risk e.g. near eyes, ill defined etc. (consider Moh's surgery if recurrence of previous cancer) - Radiotherapy in poor surgical candidates - Other options for smaller lesions e.g. curettage and cautery Future = sun protection e.g. hats, sunscreen
36
Outline the differences between a lesion of BCC and SCC
Both tend to appear on sun-exposed areas Basal cell carcinomas: - Shiny and pearly - Don't tend to be painful or bleed - More slower growing Squamous cell carcinomas: - Irregular, ill-defined red nodule with scale and ulceration - Can be painful or bleed - More faster growing
37
Outline what Mohs micrographic surgery is and when it is used
Tissue is excised during surgery and examined under a microscope in real time This is to ensure that all the cancerous cells are removed but the maximum amount of healthy tissue is preserved This is done especially if : - Area is ill-defined macroscopically - Area is in need of preservation e.g. ear lobe or nose
38
State the general prognosis for squamous cell carcinoma
5 year survival of 99% (if detected early)
39
State how brain metastases secondary to melanoma can be managed
- Steroids (symptom management) - Immunotherapy - Surgery (less than 3 lesions) - Stereotactic radiotherapy of surgery not an option (don’t tend to do whole brain radiotherapy)
40
Outline common sites of metastasis for lung cancer
LBBA Liver Brain Bone Adrenal glands + lymph nodes
41
Outline common sites of metastasis for melanoma
LLBB Lung Liver Brain Bone + lymph nodes
42
List some causes of pneumonitis in patients undergoing lung cancer treatment
- Radiation - Immunotherapy / targeted therapies - Chemotherapy e.g. Bleomycin, Methotrexate - Tumour itself
43
Outline the presenting symptoms and signs of pneumonitis
- Dyspnoea - Chest pain (pleuritic) - Cough - Low-grade fever - Reduced O2 sats
44
What investigations are useful in diagnosing pneumonitis and results would it show?
Chest x-ray: - Airspace opacities - Pleural effusions - Atelectasis Non contrast HRCT: - Ground-glass opacities - Airspace consolidation Bronchoscopy
45
How is pneumonitis managed in lung cancer treatment?
- Consider pausing / halting treatment therapy e.g. immunotherapy - Steroids e.g. IV Methylpred then oral Prednisolone (reduce inflammation) - Ventilation / ITU may be required if severe pneumonitis - Consider antibiotics if suspicion of infection